You just read:

FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children's Hospital of Philadelphia

News provided by

Penn Medicine and Children's Hospital of Philadelphia

Aug 30, 2017, 12:06 ET